Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × camrelizumab × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Esophageal Neoplasms 3 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Gastric Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Immune Checkpoint Inhibition 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Bites and Stings 1

Interventions

Radiofrequency Ablation 5 lenvatinib 4 Radiosurgery 4 Electroporation 4 Radiotherapy 3 Hepatectomy 3 sintilimab 2 perflutren 2 Proton Therapy 2 Patient Navigation 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Exercise 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1 gadobenic acid 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05339581 2022-04-27

iPLENTY-pvtt

RenJi Hospital

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡